Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up
- 1 August 2000
- Vol. 56 (2) , 289-294
- https://doi.org/10.1016/s0090-4295(00)00627-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA resultsUrology, 1999
- Randomized, Prospective, Controlled Study Comparing Radical Prostatectomy Alone and Neoadjuvant Androgen Withdrawal in the Treatment of Localized Prostate CancerJournal of Urology, 1996
- Biochemical and Pathological Effects of 8 Months of Neoadjuvant Androgen Withdrawal Therapy Before Radical Prostatectomy in Patients with Clinically Confined Prostate CancerJournal of Urology, 1996
- Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate CancerJournal of Urology, 1995
- Neoadjuvant Hormonal Deprivation in Patients with Locally Advanced Prostate CancerJournal of Urology, 1993
- The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate CancerJournal of Urology, 1993
- Preoperative Androgen Deprivation Therapy: Artificial Lowering of Serum Prostate Specific Antigen without Downstaging the TumorJournal of Urology, 1993
- The role of neoadjuvant hormonal manipulation in localized prostatic cancerCancer, 1993
- Frequency and Location of Extracapsular Extensionand Positive Surgical Margins in Radical Prostatectomy SpecimensJournal of Urology, 1992
- Resection Margin Status in Radical Retropubic Prostatectomy Specimens: Relationship to Type of Operation, Tumor Size, Tumor Grade and Local Tumor ExtensionJournal of Urology, 1990